	US 11,793,838 B2
	Stenting-free pharmaceutical composition for treatment of cardiovascular and cerebrovascular disease
Jinchang Ai, Yueyang (CN); and Wu Tang, Yueyang (CN)
Assigned to Yueyang Traditional Chinese Medicine Hospital, Yueyang (JP)
Filed by Yueyang Traditional Chinese Medicine Hospital, Yueyang (CN)
Filed on May 13, 2021, as Appl. No. 17/320,194.
Prior Publication US 2022/0362307 A1, Nov. 17, 2022
Int. Cl. A61K 35/62 (2006.01); A61K 36/258 (2006.01); A61K 36/537 (2006.01); A61K 36/236 (2006.01); A61K 36/8988 (2006.01); A61P 9/10 (2006.01); A61K 36/88 (2006.01); A61K 36/28 (2006.01); A61K 36/16 (2006.01); A61K 36/484 (2006.01); A61K 36/734 (2006.01)

CPC A61K 35/62 (2013.01) [A61K 36/16 (2013.01); A61K 36/236 (2013.01); A61K 36/258 (2013.01); A61K 36/28 (2013.01); A61K 36/484 (2013.01); A61K 36/537 (2013.01); A61K 36/734 (2013.01); A61K 36/88 (2013.01); A61K 36/8988 (2013.01); A61P 9/10 (2018.01)]

16 Claims

1. A traditional Chinese medicine (TCM) composition for the treatment of cardiovascular and cerebrovascular diseases, comprising the following raw materials: Radix Panacis Quinquefolii, Pheretima, Radix et Rhizoma Salviae Miltiorrhizae, Hirudo, Rhizoma Ligustici Chuanxiong, Rhizoma Gastrodiae, Fructus Crataegi, Stigma Croci, Herba Erigerontis, Semen Ginkgo, and Radix et Rhizoma Glycyrrhizae,

wherein the TCM composition is in the form of a pill or a capsule.